Pathophysiological Rationale For The Use Of A New Amino Acid Mixture For Liver Damage

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/7395

Full metadata record

DC Field	Value	Language
dc.contributor.author	Sayfutdinova, Z.A.	-
dc.contributor.author	Kurbonova, Z.Ch.	-
dc.contributor.author	Sadikova, N.M.	-
dc.contributor.author	Gulyamov, N.G.	-
dc.contributor.author	Erdogan, Filiz M.	-
dc.contributor.author	Xashimova, G.	-
dc.date.accessioned	2023-05-02T18:40:47Z	-
dc.date.available	2023-05-02T18:40:47Z	-
dc.date.issued	2023-04	-
dc.identifier.issn	2660-5589	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/7395	-
dc.description.abstract	The main causes of chronic hepatitis and liver cirrhosis is infection with hepatitis B and C. The most dangerous types of hemotransmissive infections include hepatitis B, C and D. At the same time, more than 180 hepatotoxic drugs have been identified, of which 6 groups seriously injure the liver. At the same time, 50% of drugs are hepatotoxic, especially in women this effect is more pronounced	en_US
dc.language.iso	en	en_US
dc.publisher	European Journal of Humanities and Educational Advancements	en_US
dc.relation.ispartofseries	4;	-
dc.subject	Pathophysiological rationale, new amino acid mixture, liver damage	en_US
dc.title	Pathophysiological Rationale For The Use Of A New Amino Acid Mixture For Liver Damage	en_US
dc.type	Article	en_US
Appears in Collections:	Books and Book Chapters

Files in This Item:

File	Description	Size	Format
2023 EJHEA Pathophysiological Rationale For The Use Of A New Amino Acid Mixture For Liver Damage.pdf		530.61 kB	Adobe PDF	View/Open

DSpace JSPUI